Date:
August 9, 2021
Issue #:
1630
Summary:
On July 12, 2021, the FDA added a warning to the
Fact Sheet for the Johnson & Johnson (Janssen)
adenovirus-based COVID-19 vaccine about an
increased risk of Guillain-Barré syndrome (GBS)
following administration of the product.
Fact Sheet for the Johnson & Johnson (Janssen)
adenovirus-based COVID-19 vaccine about an
increased risk of Guillain-Barré syndrome (GBS)
following administration of the product.
